Stay updated on TNB-383B Study in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the TNB-383B Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the TNB-383B Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- Check6 days agoChange DetectedThe footer’s ClinicalTrials.gov revision number changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check13 days agoChange DetectedA sitewide notice explains that federal agencies are transitioning to the term “Super Intelligence” in place of “Artificial Intelligence,” with updates and FAQs available.SummaryDifference0.5%

- Check20 days agoChange DetectedThe footer revision label was updated from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check27 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check48 days agoChange DetectedA new site revision entry was added to the history (v3.7.0), replacing the previous revision (v3.6.6). This indicates an update to the ClinicalTrials.gov interface and related functionality.SummaryDifference0.1%

- Check69 days agoChange DetectedA new revision entry v3.6.6 has been added to the record history, and the previous revision v3.6.5 has been removed, updating the page’s revision timeline.SummaryDifference0.1%

Stay in the know with updates to TNB-383B Study in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TNB-383B Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page.